Kanvas Biosciences
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $48.0Mattributed |
|---|---|
| Latest round | series-a, $48.0M, 2025-01-01attributed |
| Founded | 2021 |
| Headquarters | US |
| Industry | bio |
| Stage | series-a |
| Website | kanvasbio.com |
Kanvas Biosciences is a spatial biology company building a microbiome drug discovery and manufacturing platform. It serves developers of live biotherapeutics, with an in-house immuno-oncology pipeline. Its Spectral Lightsheet and probes map microbial identity and function to train an AI engine.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | series-a | $48.0M | undisclosed |
Detected tech stack
Cloudflare, Google Analytics, Google Tag Manager, SEOmatic, DoubleClick Floodlight, WordPress, Craft CMS, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $48.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $48.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | kanvasbio.com, read 2026-05-08 |
| Description | self-reported | kanvasbio.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.